Fagron (FAGR.BR) traded up 1.07 % during a 24 hours period ending at 12:22 AM Central Europe on Tuesday 27th. One Fagron stock can currently be bought for about EUR 23.35 on popular exchanges. Current supply of Fagron stocks is 73.4 mn. Fagron has a current market capitalization of EUR 1.7 bn and approximately EUR 2.2 mn worth of Fagron was traded on exchanges in the last 24 hours. Since last month end, Fagron has traded 7.99 % up. Simple moving average of last 200 days is at EUR 22.96. The highest price of past 52 weeks was recorded at EUR 25.3 on 05/27/2026. 52 weeks low was at EUR 20 on 12/09/2025.

Here is how related stocks have performed in the past 24 hours:

  • Kinepolis (KIN.BR) traded down -0.21 % and now trades at EUR 48.8. Current market capitalisation for Kinepolis is EUR 1.3 bn. Current price/earnings ratio for Kinepolis is 22.86.

  • Lakefront Biotherapeutics (LKFT.AS) traded up 1.88 % and now trades at EUR 28.22. Lakefront Biotherapeutics has a market capitalisation of EUR 1.8 bn. Lakefront Biotherapeutics has a current price to earnings ratio of 3.11.

  • Gimv (GIMB.BR) traded up 2.94 % and now trades at EUR 49. Current market capitalisation for Gimv is EUR 1.8 bn. Gimv has a current price to earnings ratio of 6.72.

  • Orange Belgium (OBEL.BR) traded flat 0 % and now trades at EUR 22.2. Orange Belgium has a market capitalisation of EUR 1.5 bn. Current price/earnings ratio for Orange Belgium is 26.29.

  • Proximus (PROX.BR) traded down -2.22 % and now trades at EUR 5.58. Current market capitalisation for Proximus is EUR 1.8 bn.

About Fagron

Fagron NV is a health care provider and service company operating through four segments: Fagron Europe, Fagron South America, Fagron North America, and HL Technology. The company specializes in providing customized medication compounding services to hospitals, pharmacies, clinics, and patients globally. Established in 1990 and located in Nazareth, Belgium, Fagron prepares personalized medications in its sterile and non-sterile facilities. Additionally, the company innovates various concepts, products, and vehicles developed by Fagron. Furthermore, it supplies conditioned, repackaged, and distributed pharmaceutical raw materials, supplies, and equipment necessary for pharmacists to prepare medication in the pharmacy. Fagron also develops and produces precision components and orthopedic tools for dental and medical industry professionals. The company was previously known as Arseus NV but changed its name to Fagron NV in January 2015.